SCHEMBL547665

SCHEMBL547665

CCCc1ccccc1C=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
THRB P10828 1/20 0.50
BLM P54132 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 4/20 0.46
TSHR P16473 1/20 0.46
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
LIPG Q9Y5X9 1/20 0.37
MITF O75030 1/20 0.36
CTSL P07711 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
GAA P10253 2/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL14237094 0.98 LMNA (0.48) LMNAKMT2AMEN1THRBBLM
SCHEMBL11273327 0.94 MEN1 (0.44) LMNAKMT2AMEN1THRBBLM
Pyrrole SCHEMBL28825319 0.91 MEN1 (0.41) LMNAKMT2AMEN1THRBBLM
SCHEMBL9949991 0.89 MEN1 (0.40) LMNAKMT2AMEN1THRBBLM
SCHEMBL266417 0.88 LIPG (0.47) LMNAKMT2AMEN1THRBBLM
SCHEMBL617128 0.86 LIPG (0.55) LMNAKMT2AMEN1THRBBLM
SCHEMBL31734211 0.86 LIPG (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL9859793 0.84 LIPG (0.58) LMNAKMT2AMEN1THRBBLM
SCHEMBL5171915 0.84 LIPG (0.58) LMNAKMT2AMEN1THRBBLM
SCHEMBL20594223 0.84 LIPG (0.58) LMNAKMT2AMEN1THRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 544 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116836478-B Heat-insulating transparent polypropylene material and preparation method and application thereof 金发科技股份有限公司 2025-03-04 CN claimed
CN-110891562-B Lithium salts of N-substituted glycine compounds and uses thereof 心悦生医股份有限公司 2024-07-16 CN claimed
CN-118271744-A Polypropylene composite material and preparation method and application thereof 金发科技股份有限公司 2024-07-02 CN claimed
WO-2024067000-A1 POLYETHYLENE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF 武汉金发科技有限公司 2024-04-04 WO claimed
CN-116836478-A Heat-insulating transparent polypropylene material and preparation method and application thereof 金发科技股份有限公司 2023-10-03 CN claimed
CN-111587403-B Composition for hard mask 东友精细化工有限公司 2023-09-19 CN claimed
CN-115418044-B Polyethylene composition and preparation method and application thereof 武汉金发科技有限公司 2023-08-08 CN claimed
CN-114031846-B Polypropylene composition with low plastic deformation and high elastic recovery, and preparation method and application thereof 金发科技股份有限公司 2023-06-06 CN claimed
CN-115418044-A Polyethylene composition, preparation method and application thereof 武汉金发科技有限公司 2022-12-02 CN claimed
CN-114410005-A Anti-bending flame-retardant polypropylene composite material and preparation method and application thereof 武汉金发科技有限公司 2022-04-29 CN claimed
EP-2660257-A1 AROMATIC HYDROCARBON RESIN, COMPOSITION FOR FORMING LITHOGRAPHIC UNDERLAYER FILM, AND METHOD FOR FORMING MULTILAYER RESIST PATTERN Mitsubishi Gas Chemical Company, Inc. (JP) 2013-11-06 EP claimed
US-20130280655-A1 AROMATIC HYDROCARBON RESIN, UNDERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY, AND METHOD FOR FORMING MULTILAYER RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-10-24 US claimed
EP-2479198-A1 AROMATIC HYDROCARBON RESIN AND COMPOSITION FOR FORMING UNDERLAYER FILM FOR LITHOGRAPHY Mitsubishi Gas Chemical Company, Inc. (JP) 2012-07-25 EP claimed
US-20120171611-A1 AROMATIC HYDROCARBON RESIN AND COMPOSITION FOR FORMING UNDERLAYER FILM FOR LITHOGRAPHY MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-07-05 US claimed
US-20030022923-A1 Methods for treatment of sickle cell anemia MEDINOX, INC. 2003-01-30 US claimed
EP-1173174-A4 METHODS FOR TREATMENT OF SICKLE CELL ANEMIA MEDINOX INC (US) 2002-09-18 EP claimed
US-6355661-B1 STABILITY OF ALDEHYDES AND PROTECTED ALDEHYDES MEDINOX, INC. 2002-03-12 US claimed
EP-1173174-A1 METHODS FOR TREATMENT OF SICKLE CELL ANEMIA Medinox, Inc. (US) 2002-01-23 EP claimed
US-6251927-B1 TREATING SICKLE CELL ANEMIA USING PROTECTED FORMS OF ORGANIC ALDEHYDES MEDINOX, INC. 2001-06-26 US claimed
WO-2000062777-A1 METHODS FOR TREATMENT OF SICKLE CELL ANEMIA MEDINOX, INC. (US) 2000-10-26 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030022923-A1 Methods for treatment of sickle cell anemia SORD, HBG1, HBG2 LMNA 1027/4885KMT2A 1100/4885MEN1 4307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.